Related Experiment Videos
[Serum lipoproteins: characteristics and metabolism (author's transl)]
Lijecnicki Vjesnik
|February 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Alirocumab: targeting PCSK9 to treat hypercholesterolemia.
Drugs of today (Barcelona, Spain : 1998)·2016
Resistance and intolerance to statins.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2013
SURF - SUrvey of Risk Factor management: first report of an international audit.
European journal of preventive cardiology·2012
[AUTONOMIC DYSREFLEXIA].
Lijecnicki vjesnik·2018
[ASSESSMENT OF QUALITY OF LIFE IN GLAUCOMA PATIENTS].
Lijecnicki vjesnik·2018
[HBsAg SEROCONVERSION IN THE TREATMENT OF CHRONIC HEPATITIS B WITH PEGYLATED INTERFERON].
Lijecnicki vjesnik·2018
[FEMUR FRACTURES IN CHILDREN – CAUSES AND MECHANISMS OF INJURY].
Lijecnicki vjesnik·2018
Orbital Septal Fascial Flap with Extensive Release of a Long Orbital Fat Flap for Correcting Lower Eyelid Bags Associated with Midface Depression.
Journal of visualized experiments : JoVE·2026
Adipose-derived microRNA-518a drives hepatic cholesterol dysregulation and hypertension-related vascular remodeling in metabolic dysfunction-associated steatohepatitis via the MST1-AMPK-SREBP2 axis.
Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Extracellular Vesicle Surface Protein Profiling in Metabolic Dysfunction-associated Steatotic Liver Disease in Obesity.
Journal of extracellular biology·2026
Prevalence and Associated Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease Across Obesity Metabolic Phenotypes in Chronic Schizophrenia.
International journal of general medicine·2026
The association between BMI and cognition, disability, and quality of life markers in multiple sclerosis: DISCOMS secondary analysis.
Therapeutic advances in neurological disorders·2026